Elevance Reports Stable Medicare Advantage Costs Amid Market Volatility
Elevance Health's Q1 report shows Medicare Advantage utilization in line with expectations, Medicaid rate progress, and ACA expansion amid market volatility.
Medicare Coverage and Costs for Diabetes Medications Including Metformin
Explore how Medicare covers diabetes treatments and costs including Metformin and other diabetic supplies under Parts A, B, C, and D. Understand cost factors like premiums and deductibles.
Trump Administration Ends Federal Medicaid Funding for Non-Healthcare Services
The Trump administration has ceased federal Medicaid funding for non-healthcare services, refocusing resources on core medical benefits amid rising spending on social determinants of health programs in several states.
Medicare Advantage Market Growth Slows in Early 2025, Reports MFA
Mark Farrah Associates reports a slowdown in Medicare Advantage market growth with detailed enrollment and market share data for early 2025. Key tools aid insurers in competitive analysis post-Open Enrollment Period.
Healthcare Sector Faces Mixed Market Trends Amid Insurer Losses and Pharma Gains
April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.
Nexalin Backing Senate Bill to Expand Medicare AI Device Reimbursement
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.
Medicare Advantage Costs, Challenges, and Broker Roles: Insights from SCAN Health Plan CEO
Medicare Advantage increases federal spending but offers lower out-of-pocket costs for seniors. SCAN CEO Sachin Jain highlights program flaws, risk adjustment abuses, and broker roles.
Strategies to Reduce Medicare Out-of-Pocket Costs and Improve Care Access
Explore effective strategies for Medicare beneficiaries to reduce out-of-pocket healthcare costs, optimize insurance plans, and navigate coverage challenges in 2025.
Health Tech Investment Act Seeks to Expand Medicare AI Device Reimbursement
The Health Tech Investment Act proposes expanded Medicare reimbursement for FDA-approved AI medical devices, supported by Nexalin Technology to improve access and innovation in healthcare.
U.S. Pharmaceutical Regulation and Pricing: April 2025 Update
April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.